Zymeworks ZYME Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Operating margin | -140.4%-6.6pp | -87.3%+92.3pp | -52.5%+170pp | -67.3%+152pp | -133.8%+161pp | |
| Net margin | -126.3%-4.6pp | -76.6%+84.2pp | -47.2%+136pp | -60%+119pp | -121.7%+128pp | |
| EBITDA margin | -132.6%-9.1pp | -80%+88.3pp | -45.3%+164pp | -59.1%+146pp | -123.6%+152pp | |
| Free cash flow margin | -94.8%— | -32.6%— | -48.7%— | —— | —— | |
| Returns | ||||||
| Return on equity | -42%-12.2pp | -26.7%+3.8pp | -18.5%+10.3pp | -19.9%+6.4pp | -29.8%-2.2pp | |
| Return on assets | -22.7%+0.5pp | -20%+3.5pp | -14.3%+7.4pp | -15.9%+4.2pp | -23.2%— | |
| Efficiency | ||||||
| Asset turnover | 0.2×0.0× | 0.3×+0.1× | 0.3×+0.2× | 0.3×+0.2× | 0.2×— | |
| Liquidity | ||||||
| Current ratio | 10.8×+6.1× | 5.9×+2.5× | 6.9×+2.8× | 7.7×+0.7× | 4.7×-2.2× | |
| Quick ratio | 10.8×+6.1× | 5.9×+2.5× | 6.9×+2.8× | 7.7×+0.7× | 4.7×-2.2× | |
| Cash ratio | 6.9×+5.7× | 1×+0.2× | 1.5×+0.1× | 2.6×+1.3× | 1.2×-0.8× | |
| Leverage | ||||||
| Debt-to-equity | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Debt-to-assets | 0×0.0× | 0.1×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Interest coverage | -9×-1.9× | -6.9×-0.1× | -4.9×+1.7× | -5.3×+1.2× | -7.2×0.0× | |
| Per Share | ||||||
| Book value per share | $2.19-49.3% | $3.56-20.3% | $4.22-12.3% | $4.32-18.7% | $4.32-24.8% | |
| Valuation | ||||||
| Market capitalization | $1.86B+125% | $1.99B+96.9% | $1.29B+45.8% | $959.51M+82.8% | $828.66M+52.6% | |
| Enterprise value | $1.63B+112% | $1.96B+104% | $1.25B+58.9% | $879.93M+85.6% | $770.93M+70.0% | |
| Price / sales | 22.9×+14.0× | 18.7×+5.5× | 9.6×-4.6× | 7.8×-0.6× | 8.9×-1.9× | |
| Price / book | 11.4×+8.8× | 7.4×+4.4× | 4×+1.6× | 2.9×+1.6× | 2.6×+1.3× | |
| EV / sales | 20.1×+11.8× | 18.5×+5.9× | 9.3×-3.3× | 7.2×-0.4× | 8.3×-0.7× | |
| Free cash flow yield | -4.1%— | -1.7%— | -5.1%— | —— | —— | |
| Earnings yield | -5.5%+8.2pp | -4.1%+8.1pp | -4.9%+7.9pp | -7.7%+13.8pp | -13.7%+9.5pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Zymeworks's ratios come from?
- Every ratio is computed from Zymeworks's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.